封面
市場調查報告書
商品編碼
1378941

藥物警戒市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球藥物警戒市場規模達73億美元。展望未來, IMARC Group預計到2028年市場規模將達到121億美元,2022-2028年複合年成長率(CAGR)為8.8%。

藥物警戒(PV)是涉及檢測、評估、了解和預防藥物不良反應的藥理科學。它在識別以前未知的不良反應、識別頻率或嚴重程度的變化以及評估藥物的風險和益處以確定所需的行動方面發揮關鍵作用。它還確保向醫療保健專業人員和患者傳達的訊息的準確性。目前,PV 被廣泛用於了解藥物對全世界個體的影響。

藥物警戒市場趨勢:

高血壓、糖尿病和心臟病等生活方式疾病的盛行率不斷上升,導致全球藥物消費量不斷增加。這與不斷增加的藥物不良反應 (ADR) 發生率相結合,是推動全球藥物警戒市場的關鍵因素之一。除此之外,主要參與者正在引入先進的平台來確保自動 ADR 報告,這有助於市場成長。鑑於競爭環境,他們也專注於改善製造營運並簡化研發 (R&D)。此外,領先的製藥公司正在採取許多舉措來進行臨床試驗並提高人們對正確使用藥物的認知。這反過來又促進了藥物警戒市場的成長。此外,冠狀病毒病(COVID-19)的爆發導致對疫苗的迫切需求,這為市場參與者創造了眾多機會。除此之外,考慮到相關的好處,例如提高內部資源靈活性和在更短的時間內獲得更好的結果,藥廠正在​​轉向將藥物警戒業務外包給第三方。

本報告回答的關鍵問題:

  • 迄今為止,全球藥物警戒市場的表現如何,未來幾年將如何表現?
  • COVID-19 對全球藥物警戒市場有何影響?
  • 主要區域市場有哪些?
  • 基於服務提供者的市場區隔是什麼?
  • 基於產品生命週期的市場區隔是怎樣的?
  • 依類型分類市場是怎麼樣的?
  • 根據流程分類市場是怎麼樣的?
  • 基於治療領域的市場區隔是什麼?
  • 根據最終用途分類的市場是怎樣的?
  • 產業價值鏈的各個階段是什麼?
  • 該行業的關鍵促進因素和挑戰是什麼?
  • 全球藥物警戒市場的結構如何?誰是主要參與者?
  • 產業競爭程度如何?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球藥物警戒市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:按服務提供者分類的市場細分

  • 內部
    • 市場走向
    • 市場預測
  • 合約外包
    • 市場走向
    • 市場預測

第 7 章:按產品生命週期分類的市場

  • 臨床前
    • 市場走向
    • 市場預測
  • 第一階段
    • 市場走向
    • 市場預測
  • 第二階段
    • 市場走向
    • 市場預測
  • 第三階段
    • 市場走向
    • 市場預測
  • 第四階段
    • 市場走向
    • 市場預測

第 8 章:按類型分類的市場區隔

  • 自發性報告
    • 市場走向
    • 市場預測
  • 強化 ADR 報告
    • 市場走向
    • 市場預測
  • 針對性的自發性報告
    • 市場走向
    • 市場預測
  • 群組事件監控
    • 市場走向
    • 市場預測
  • 電子病歷採礦
    • 市場走向
    • 市場預測

第 9 章:依製程分類的市場

  • 案例資料管理
    • 市場走向
    • 主要類型
      • 案例記錄
      • 案例數據分析
      • 醫學審查和報告
    • 市場預測
  • 訊號檢測
    • 市場走向
    • 主要類型
      • 不良事件記錄
      • 不良事件分析
      • 不良事件審查和報告
    • 市場預測
  • 風險管理系統
    • 市場走向
    • 主要類型
      • 風險評估體系
      • 風險緩釋系統
    • 市場預測

第 10 章:按治療領域分類的市場細分

  • 腫瘤學
    • 市場走向
    • 市場預測
  • 神經病學
    • 市場走向
    • 市場預測
  • 心臟病學
    • 市場走向
    • 市場預測
  • 呼吸系統
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章:依最終用途分類的市場細分

  • 製藥公司
    • 市場走向
    • 市場預測
  • 生技公司
    • 市場走向
    • 市場預測
  • 醫療器材公司
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 12 章:按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 13 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 14 章:價值鏈分析

第 15 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 16 章:價格分析

第17章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accenture plc
    • ArisGlobal LLC
    • BioClinica Inc. (Cinven Partners LLP)
    • Capgemini
    • Cognizant
    • International Business Machines Corporation
    • ICON plc.
    • IQVIA Inc.
    • ITClinical
    • Parexel International Corporation
    • Wipro Limited
Product Code: SR112023A3609

Abstract

The global pharmacovigilance market size reached US$ 7.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2022-2028.

Pharmacovigilance (PV) is the pharmacological science concerning the detection, assessment, understanding and prevention of unfavorable effects with pharmaceutical products. It plays a pivotal role in identifying previously unknown adverse effects, recognizing changes in the frequency or severity, and assessing the risks and benefits of drugs to determine required actions. It also ensures the accuracy of communicated information to healthcare professionals and patients. At present, PV is widely used to understand the effects of drugs on individuals worldwide.

Pharmacovigilance Market Trends:

The increasing prevalence of lifestyle diseases, such as hypertension, diabetes, and cardiac disorders, has resulted in the rising consumption of drugs worldwide. This, in confluence with the growing incidences of adverse drug reactions (ADRs), represents one of the key factors driving the global pharmacovigilance market. Besides this, the key players are introducing advanced platforms to ensure automated ADR reporting, which is contributing to the market growth. They are also focusing on improving the manufacturing operations and streamlining research and development (R&D) on account of a competitive environment. Furthermore, leading pharmaceutical companies are undertaking numerous initiatives to conduct clinical trials and generate awareness about the proper utilization of medicines. This, in turn, is facilitating the growth of the pharmacovigilance market. Additionally, the coronavirus disease (COVID-19) outbreak has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Apart from this, pharmaceutical manufacturers are shifting towards outsourcing pharmacovigilance operations to third parties on account of the associated benefits, such as increasing internal resource flexibility and better outcomes over shorter periods.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacovigilance market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service provider, product life cycle, type, process flow, therapeutic area and end use.

Breakup by Service Provider:

In-house

Contract Outsourcing

Breakup by Product Life Cycle:

Pre-clinical

Phase I

Phase II

Phase III

Phase IV

Breakup by Type:

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Breakup by Process Flow:

Case Data Management

Case Logging

Case Data Analysis

Medical Reviewing and Reporting

Signal Detection

Adverse Event Logging

Adverse Event Analysis

Adverse Event Review and Reporting

Risk Management System

Risk Evaluation System

Risk Mitigation System

Breakup by Therapeutic Area:

Oncology

Neurology

Cardiology

Respiratory Systems

Others

Breakup by End Use:

Pharmaceuticals Companies

Biotechnology Companies

Medical Device Companies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation and Wipro Limited.

Key Questions Answered in This Report:

  • How has the global pharmacovigilance market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmacovigilance market?
  • What are the key regional markets?
  • What is the breakup of the market based on the service provider?
  • What is the breakup of the market based on the product life cycle?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the process flow?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmacovigilance market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmacovigilance Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Service Provider

  • 6.1 In-house
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Contract Outsourcing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Life Cycle

  • 7.1 Pre-clinical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Phase I
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phase II
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Phase III
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Phase IV
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Type

  • 8.1 Spontaneous Reporting
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intensified ADR Reporting
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Targeted Spontaneous Reporting
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cohort Event Monitoring
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 EHR Mining
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Process Flow

  • 9.1 Case Data Management
    • 9.1.1 Market Trends
    • 9.1.2 Major Types
      • 9.1.2.1 Case Logging
      • 9.1.2.2 Case Data Analysis
      • 9.1.2.3 Medical Reviewing and Reporting
    • 9.1.3 Market Forecast
  • 9.2 Signal Detection
    • 9.2.1 Market Trends
    • 9.2.2 Major Types
      • 9.2.2.1 Adverse Event Logging
      • 9.2.2.2 Adverse Event Analysis
      • 9.2.2.3 Adverse Event Review and Reporting
    • 9.2.3 Market Forecast
  • 9.3 Risk Management System
    • 9.3.1 Market Trends
    • 9.3.2 Major Types
      • 9.3.2.1 Risk Evaluation System
      • 9.3.2.2 Risk Mitigation System
    • 9.3.3 Market Forecast

10 Market Breakup by Therapeutic Area

  • 10.1 Oncology
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Neurology
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Cardiology
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Respiratory Systems
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by End Use

  • 11.1 Pharmaceuticals Companies
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Biotechnology Companies
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Medical Device Companies
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Others
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Accenture plc
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 ArisGlobal LLC
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
    • 17.3.3 BioClinica Inc. (Cinven Partners LLP)
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 SWOT Analysis
    • 17.3.4 Capgemini
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
    • 17.3.5 Cognizant
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 International Business Machines Corporation
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 Financials
      • 17.3.6.4 SWOT Analysis
    • 17.3.7 ICON plc.
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 IQVIA Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
      • 17.3.8.4 SWOT Analysis
    • 17.3.9 ITClinical
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
    • 17.3.10 Parexel International Corporation
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
      • 17.3.10.3 SWOT Analysis
    • 17.3.11 Wipro Limited
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
      • 17.3.11.3 Financials
      • 17.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmacovigilance Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmacovigilance Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmacovigilance Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmacovigilance Market: Breakup by Service Provider (in %), 2022
  • Figure 5: Global: Pharmacovigilance Market: Breakup by Product Life Cycle (in %), 2022
  • Figure 6: Global: Pharmacovigilance Market: Breakup by Type (in %), 2022
  • Figure 7: Global: Pharmacovigilance Market: Breakup by Process Flow (in %), 2022
  • Figure 8: Global: Pharmacovigilance Market: Breakup by Therapeutic Area (in %), 2022
  • Figure 9: Global: Pharmacovigilance Market: Breakup by End Use (in %), 2022
  • Figure 10: Global: Pharmacovigilance Market: Breakup by Region (in %), 2022
  • Figure 11: Global: Pharmacovigilance (In-house) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pharmacovigilance (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pharmacovigilance (Contract Outsourcing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pharmacovigilance (Contract Outsourcing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pharmacovigilance (Pre-clinical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pharmacovigilance (Pre-clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Pharmacovigilance (Phase I) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Pharmacovigilance (Phase I) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Pharmacovigilance (Phase II) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Pharmacovigilance (Phase II) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Pharmacovigilance (Phase III) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Pharmacovigilance (Phase III) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Pharmacovigilance (Phase IV) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Pharmacovigilance (Phase IV) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Pharmacovigilance (Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Pharmacovigilance (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Pharmacovigilance (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Pharmacovigilance (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Pharmacovigilance (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Pharmacovigilance (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Pharmacovigilance (EHR Mining) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Pharmacovigilance (EHR Mining) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Pharmacovigilance (Case Data Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Pharmacovigilance (Case Data Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Pharmacovigilance (Signal Detection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Pharmacovigilance (Signal Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Pharmacovigilance (Risk Management System) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Pharmacovigilance (Risk Management System) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Pharmacovigilance (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Pharmacovigilance (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Pharmacovigilance (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Pharmacovigilance (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Pharmacovigilance (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Pharmacovigilance (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Pharmacovigilance (Respiratory Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Pharmacovigilance (Respiratory Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Pharmacovigilance (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Pharmacovigilance (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Pharmacovigilance (Pharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Pharmacovigilance (Pharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Global: Pharmacovigilance (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Global: Pharmacovigilance (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Global: Pharmacovigilance (Medical Device Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Global: Pharmacovigilance (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Global: Pharmacovigilance (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Global: Pharmacovigilance (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: North America: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: North America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United States: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United States: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Canada: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Canada: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Asia-Pacific: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Asia-Pacific: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: China: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: China: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Japan: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Japan: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: India: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: India: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: South Korea: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: South Korea: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Australia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Australia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Indonesia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Indonesia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Europe: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Europe: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Germany: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Germany: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: France: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: France: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: United Kingdom: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: United Kingdom: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Italy: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Italy: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Spain: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Spain: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Russia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Russia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Latin America: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Latin America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Brazil: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Brazil: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Mexico: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 102: Mexico: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 103: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 104: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 105: Middle East and Africa: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 106: Middle East and Africa: Pharmacovigilance Market: Breakup by Country (in %), 2022
  • Figure 107: Middle East and Africa: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 108: Global: Pharmacovigilance Industry: SWOT Analysis
  • Figure 109: Global: Pharmacovigilance Industry: Value Chain Analysis
  • Figure 110: Global: Pharmacovigilance Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmacovigilance Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmacovigilance Market Forecast: Breakup by Service Provider (in Million US$), 2023-2028
  • Table 3: Global: Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (in Million US$), 2023-2028
  • Table 4: Global: Pharmacovigilance Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 5: Global: Pharmacovigilance Market Forecast: Breakup by Process Flow (in Million US$), 2023-2028
  • Table 6: Global: Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
  • Table 7: Global: Pharmacovigilance Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 8: Global: Pharmacovigilance Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Pharmacovigilance Market: Competitive Structure
  • Table 10: Global: Pharmacovigilance Market: Key Players